RecruitingNot ApplicableNCT06092814

tACS to Enhance Language Abilities

Transcranial Alternating Current Stimulation (tACS) to Enhance Language Abilities

Sponsor

University of Pennsylvania

Enrollment

120 participants

Start Date

Jul 12, 2024

Study Type

INTERVENTIONAL

Conditions

Stroke Aphasia Aphasia, Acquired

Summary

The goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke aphasia. Participants will receive real and sham tACS in conjunction with various language tests. Researchers will compare the post-stroke aphasia group with aged matched controls to see if brain response to tACS differs between groups.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active transcranial alternating current stimulation (tACS) for people with aphasia, aphasia, acquired, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive transcranial alternating current stimulation (tACS)

Transcranial Alternating Current Stimulation (tACS) is a device that applies a low-intensity electrical current to the brain through electrodes on the scalp.